We are live on
!
Find out more
HWAM
Hennion & Walsh Asset Management Portfolio holdings
AUM
$3.5B
1-Year Est. Return
41.95%
This Fund
S&P 500
This Quarter
Est. Return
+6.05%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
–
AUM
$1.69B
AUM Growth
+$56.3M
(+3.5%)
Cap. Flow
+$7.4M
Cap. Flow
% of AUM
0.44%
Top 10 Holdings %
Top 10 Hldgs %
18.14%
Holding
856
New
82
Increased
316
Reduced
389
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan US Quality Factor ETF
JQUA
|
+$35.1M |
| 2 |
WisdomTree International Quality Dividend Growth Fund
IQDG
|
+$19.5M |
| 3 |
Invesco S&P 500 Equal Weight Technology ETF
RSPT
|
+$12.3M |
| 4 |
VanEck Long Muni ETF
MLN
|
+$6.31M |
| 5 |
iShares Investment Grade Systematic Bond ETF
IGEB
|
+$3.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Value ETF
VTV
|
+$19.1M |
| 2 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$15.4M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$14.1M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$12.9M |
| 5 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$12.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.66% |
| 2 | Financials | 9.78% |
| 3 | Technology | 8.27% |
| 4 | Industrials | 5.45% |
| 5 | Consumer Staples | 4.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Avery Dennison
AVY
$13.6B
| $987K | 0.06% |
5,745
+3,306
| +136% | +$565K |
|
377
Arcutis Biotherapeutics
ARQT
$3.35B
| $976K | 0.06% |
102,413
-34,391
| -25% | -$382K |
|
378
Equifax
EFX
$21.4B
| $970K | 0.06% |
4,123
+822
| +25% | +$173K |
|
379
O'Reilly Automotive
ORLY
$75.8B
| $966K | 0.06% |
15,165
-105
| -0.7% | -$6.41K |
|
380
FedEx
FDX
$76.8B
| $952K | 0.06% |
3,842
-42
| -1% | -$9.61K |
|
|
PLYM
381
DELISTED
Plymouth Industrial REIT
PLYM
| $950K | 0.06% |
41,251
-1,848
| -4% | -$39.5K |
|
382
Fidus Investment
FDUS
$757M
| $941K | 0.06% |
48,016
-1,895
| -4% | -$35.9K |
|
|
GTY
383
Getty Realty Corp
GTY
$1.99B
| $937K | 0.06% |
27,710
+18,268
| +193% | +$621K |
|
384
W.R. Berkley
WRB
$26.1B
| $934K | 0.06% |
23,532
+1,491
| +7% | +$58.6K |
|
385
Truist Financial
TFC
$63.4B
| $924K | 0.05% |
30,437
-16,103
| -35% | -$500K |
|
386
Lincoln Electric
LECO
$15.5B
| $922K | 0.05% |
4,642
+751
| +19% | +$131K |
|
|
BNY
387
Bank of New York Mellon
BNY
$108B
| $921K | 0.05% |
20,683
-1,554
| -7% | -$66.7K |
|
388
General Dynamics
GD
$107B
| $921K | 0.05% |
4,279
-492
| -10% | -$106K |
|
|
SOR
389
Source Capital
SOR
$383M
| $917K | 0.05% |
23,922
+44
| +0.2% | +$1.65K |
|
390
Nasdaq
NDAQ
$53.6B
| $899K | 0.05% |
18,025
+1,686
| +10% | +$91.3K |
|
391
Regeneron Pharmaceuticals
REGN
$82.9B
| $899K | 0.05% |
1,251
+327
| +35% | +$252K |
|
392
Mondelez International
MDLZ
$78.3B
| $897K | 0.05% |
12,303
+1,378
| +13% | +$102K |
|
|
NSA
393
DELISTED
National Storage Affiliates Trust
NSA
| $896K | 0.05% |
25,721
-1,024
| -4% | -$38.6K |
|
|
BGX
394
Blackstone Long-Short Credit Income Fund
BGX
$138M
| $890K | 0.05% |
78,459
-488
| -0.6% | -$5.34K |
|
395
Pfizer
PFE
$153B
| $881K | 0.05% |
24,010
+3,707
| +18% | +$144K |
|
|
HIO
396
Western Asset High Income Opportunity Fund
HIO
$339M
| $872K | 0.05% |
230,640
-10
| -0% | -$38 |
|
397
Flowers Foods
FLO
$1.54B
| $869K | 0.05% |
34,944
+13,641
| +64% | +$361K |
|
398
New Jersey Resources
NJR
$5.47B
| $869K | 0.05% |
18,420
+12,145
| +194% | +$612K |
|
|
ITCI
399
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $867K | 0.05% |
13,698
+270
| +2% | +$16.8K |
|
|
CEV
400
Eaton Vance California Municipal Income Trust
CEV
$73.9M
| $863K | 0.05% |
86,380
-50,015
| -37% | -$502K |
|
Similar funds
TCM
BCP
TH
DILIC
TYCC
ACM
MSC
DAM
Hennion & Walsh Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Hennion & Walsh Asset Management held 856 positions worth $1.69B, up 3.5% from $1.63B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Hennion & Walsh Asset Management's Q2 2023 filing shows 82 new, 316 increased, 389 reduced and 59 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 834,517 shares worth $37M. The largest sale was Vanguard Morningstar Value ETF, an estimated $19.1M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Financials and Technology.
- Hennion & Walsh Asset Management's largest Q2 2023 buy was JPMorgan US Quality Factor ETF: 834,517 shares worth $37M.
- Hennion & Walsh Asset Management added most to WisdomTree International Quality Dividend Growth Fund in Q2 2023, an estimated $19.5M increase.
- Hennion & Walsh Asset Management's biggest Q2 2023 reduction was Vanguard Morningstar Value ETF, cutting an estimated $19.1M.
- Hennion & Walsh Asset Management fully exited iShares MSCI USA Quality Factor ETF in Q2 2023, selling an estimated $15.4M.
- Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $1.69B portfolio in Q2 2023.
- Hennion & Walsh Asset Management opened 82 new positions and closed 59 in Q2 2023.
- Hennion & Walsh Asset Management's portfolio value rose 3.5% quarter-over-quarter to $1.69B.
Based on Hennion & Walsh Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.